Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Approved for use in oncology care according to FDA-approved indications.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Adjuvant treatment of HER2-overexpressing node-positive or node-negative breast cancer, metastatic HER2-overexpressing breast cancer, and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
HER2-overexpressing Breast Cancer, metastatic Gastric Cancer, and gastroesophageal junction adenocarcinoma.
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Adult Acute Lymphoblastic Leukemia (ALL), Burkitt Lymphoma, and Mantle Cell Lymphoma.
Relapsed or refractory Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma prior to autologous stem cell transplant.
Approved for use in oncology care according to FDA-approved indications.
Treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant.
Targeted treatment of solid tumors and hematologic malignancies.